MetLife, Inc. Q2 2026 Earnings Recap

MetLife's stock edged up modestly by 1.6%, reflecting steady execution but lacking a clear catalyst to drive stronger investor enthusiasm amid mixed segment performance and cautious outlook signals.

Key Takeaways

• Adjusted earnings rose 15% year-over-year to approximately $1.6 billion, with EPS growth at 20%, supported by disciplined capital management.
• Group Benefits segment delivered a 25% increase in adjusted earnings, driven by favorable life underwriting and improved mortality ratios.
• Retirement and Income Solutions saw modest adjusted earnings growth of 2%, with adjusted PFOs rising 19%, highlighting selective capital deployment in global markets.
• Asia operations reported a 21% increase in adjusted earnings (25% on a constant currency basis) and 17% sales growth, led by momentum in Korea and A&H product innovation in Japan.
• Despite integration headwinds from PineBridge Investments raising expenses by ~50 bps, the direct expense ratio held steady at 12.1%, supported by AI-driven productivity gains.